MINNEAPOLIS, May 20, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will be participating in two upcoming investor conferences. Tactile Medical is scheduled to present at the William Blair 45th Annual Growth Stock Conference in Chicago on Tuesday, June 3, 2025, at 3:20 p.m. CST and at the Jefferies Global Healthcare Conference in Ne ...

Tactile Systems Technology (TCMD) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.05 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -85.71%. A quarter ago, it was expected that this medical device maker would post earnings of $0.33 per share when it actually produced earnings of $0.40, delivering a surprise of 21.21%.Over the last four quart ...

Tactile Systems (TCMD) Q1 2025 Earnings Call May 05, 2025 05:00 PM ET Company Participants ​Sam Benzinger - Investor RelationSheri Dodd - CEOElaine Birkemeyer - Chief Financial OfficerKyle Winborne - Equity ResearchShaymus Contorno - Equity Research Associate Conference Call Participants Margaret Kaczor Andrew - Research Analyst - HealthcareRyan Zimmerman - Managing Director & Medical Technology AnalystAnderson Schock - Research Analyst Operator Please standby. Welcome, ladies and gentlemen, to the First Qu ...

Tactile Systems (TCMD) Q1 2025 Earnings Call May 05, 2025 05:00 PM ET Speaker0 Please standby. Welcome, ladies and gentlemen, to the First Quarter twenty twenty five Earnings Conference Call for Tactile Medical. At this time, all participants have been placed in a listen only mode. At the end of the company's prepared remarks, we will conduct a question and answer session. Please note that this conference call is being recorded and will be available on the company's website for replay shortly. I would now l ...

Forward-Looking Statements Disclosure This presentation contains forward-looking statements. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," "continue," "confident," "outlook," "guidance," "project," "goals," "look forward," "poised," "designed," "plan," "return," "focused," "positioned," "prospects," or "remain" or the negative of these words or other variations on these words or compar ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2025 (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 3701 Wayzata Blvd, Suite 300 41-1801204 Minneapolis, Minnesota 55416 (I.R.S. Employer Identification No.) or ☐ TRANSITION REPORT PURSUANT TO SECTION ...

● Total revenue increased 0.3% year-over-year to $61.3 million ● Gross margin of 74% versus 71% in Q1 2024 ● Net loss of $3.0 million versus $2.2 million in Q1 2024 ● Adjusted EBITDA loss of $0.3 million versus positive Adjusted EBITDA of $1.0 million in Q1 2024 ● Repurchased $10.0 million of stock under the Company's share repurchase program ● Expanded launch of Nimbl to include patients with lower extremity conditions, the largest segment of the lymphedema market ● Completed launch of a new customer relat ...

MINNEAPOLIS, May 05, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the first quarter ended March 31, 2025. First Quarter 2025 Summary & Recent Business Highlights: Total revenue increased 0.3% year-over-year to $61.3 millionGross margin of 74% versus 71% in Q1 2024Net loss of $3.0 million versus $2.2 million in Q1 2024Adjusted ...

MINNEAPOLIS, April 21, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that first quarter of fiscal year 2025 financial results will be released after the market closes on Monday, May 5, 2025. Management will host a conference call with a question and answer session at 5:00 p.m. Eastern Time on May 5, 2025, to discuss the results of the quarter. Tho ...

MINNEAPOLIS, March 05, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference, which is being virtually held from March 17th – 20th. Management will participate in a virtual presentation on Tuesday, March 18th at 12:00 p.m. Eastern Time. A live audio we ...